[1] |
Shi TY, Zhu ML, He J, et al. Polymorphisms of the interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women[J]. Hum Genet, 2019, 132:301-312.
|
[2] |
崔丹丹, 于秀文, 王俊苹, 等. HPV持续感染状态对宫颈癌手术预后的影响分析[J]. 中外女性健康研究, 2019, 63:96-105.
|
[3] |
欧阳华, 刘龙飞. miR-99a对宫颈癌Hela细胞增殖影响机制研究[J]. 中华肿瘤防治杂志, 2018, 25:170-174.
|
[4] |
Liang WH, Li NY, Zhi Q, et al. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2[J]. Mol Carcinog, 2019, 58:461-473.
|
[5] |
李梦熊, 邓柳枝, 梁琼. 宫颈癌细胞系Siha和C33a中RRM2表达水平与细胞对吉西他滨敏感性的相关分析[J]. 中国药房, 2015, 13:4792-4794.
|
[6] |
Osako Y, Yoshino H, Sakaguchi T, et al. Potential tumor-suppressive role of microRNA-99a-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM2[J]. Int J Oncol, 2019, 54:1759-1770.
|
[7] |
Tao X, Ping L, Guolian P, et al. Differential expression of miRNAs in breast cancer tissues and the effect of Xihuang Pill on the expression of candidate miRNAs in breast cancer cells in vitro[J]. J Chinese Phy, 2019, 98:1-9.
|
[8] |
Shinden Y, Hirashima T, Nohata N, et al. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes[J]. J Human Genetics, 2020, 12:1-12.
|
[9] |
Zhu P, Liu J, Lu M, et al. Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)[J]. Onco Targets Ther, 2019, 27:10311-10321.
|
[10] |
徐雅杰, 张志强, 于鹤. 和厚朴酚通过上调miR-99a/b抑制HeLa细胞增殖和侵袭[J]. 医学研究杂志, 2018, 491:107-112.
|
[11] |
Jing B, Luo Y, Lin B, et al. Establishment and applica-tion of a dynamic tumor-vessel microsystem for studying different stages of tumor metastasis and evaluating anti-tumor drugs[J]. RSC Advances, 2019, 9:17137-17147.
|
[12] |
Zhang HG, Pan YW, Feng J, et al. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23:2003-2012.
|
[13] |
Lu H, Lu S, Yang D, et al. miR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy[J]. Biosci Rep, 2019, 39:BSR20181374-BSR20181381. doi: 10.1042/BSR20181374.
|
[14] |
汤琳. 核糖核苷酸还原酶M2的表达及临床病理因素与子宫颈鳞癌预后关系的研究[D]. 浙江:宁波大学, 2019:24-26.
|